Top Biotechnology companies in Sweden by EBITDA Margin

This ranking features the top 65 Biotechnology companies in Sweden ranked by EBITDA Margin, averaging a EBITDA Margin of -358.63%, for January 15, 2025.

Sweden

Biotechnology

#	Name	EBITDA Margin	Reported Date	Stock Price	Change	Country
1	OncoZenge AB (publ) 1 ONCOZ.ST	242,200.00%	Dec. 31, 2023	USD 0.45	23.08%	Sweden
2	Infant Bacterial Therapeutics AB (publ) 2 IBT-B.ST	14,998.70%	Dec. 31, 2023	USD 4.07	-5.72%	Sweden
3	BioArctic AB (publ) 3 BIOA-B.ST	47.94%	Dec. 31, 2023	USD 17.87	3.09%	Sweden
4	Genovis AB (publ.) 4 GENO.ST	40.81%	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
5	RaySearch Laboratories AB (publ) 5 RAY-B.ST	39.71%	Dec. 31, 2023	USD 20.58	0.68%	Sweden
6	BioGaia AB (publ) 6 BIOG-B.ST	38.17%	Dec. 31, 2023	USD 9.75	-0.95%	Sweden
7	Swedish Orphan Biovitrum AB (publ) 7 SOBI.ST	32.70%	Dec. 31, 2023	USD 28.64	0.87%	Sweden
8	CellaVision AB (publ) 8 CEVI.ST	30.60%	Dec. 31, 2023	USD 18.76	3.89%	Sweden
9	I-Tech AB 9 ITECH.ST	25.11%	Dec. 31, 2023	USD 4.99	0.68%	Sweden
10	Biotage AB (publ) 10 BIOT.ST	23.20%	Dec. 31, 2023	USD 11.98	-2.51%	Sweden
11	Xvivo Perfusion AB (publ) 11 XVIVO.ST	21.18%	Dec. 31, 2023	USD 42.37	0.78%	Sweden
12	Vimian Group AB (publ) 12 VIMIAN.ST	20.86%	Dec. 31, 2023	USD 3.41	3.24%	Sweden
13	Getinge AB (publ) 13 GETI-B.ST	18.63%	Dec. 31, 2023	USD 16.63	0.49%	Sweden
14	Magle Chemoswed Holding AB (publ) 14 MAGLE.ST	18.43%	Dec. 31, 2023	USD 3.31	2.33%	Sweden
15	Probi AB (publ) 15 PROB.ST	18.42%	Dec. 31, 2023	USD 31.10	0.68%	Sweden
16	Elekta AB (publ) 16 EKTA-B.ST	18.16%	April 30, 2024	USD 5.39	-0.39%	Sweden
17	AddLife AB (publ) 17 ALIF-B.ST	15.96%	Dec. 31, 2023	USD 12.08	1.50%	Sweden
18	Alzinova AB (publ) 18 ALZ.ST	15.56%	Dec. 31, 2023	USD 0.29	0.68%	Sweden
19	Boule Diagnostics AB (publ) 19 BOUL.ST	11.55%	Dec. 31, 2023	USD 0.89	14.73%	Sweden
20	C-Rad AB (publ) 20 CRAD-B.ST	11.52%	Dec. 31, 2023	USD 2.57	-0.02%	Sweden
21	Integrum AB (publ) 21 INTEG-B.ST	8.41%	April 30, 2024	USD 1.60	-0.43%	Sweden
22	Bonesupport Holding AB (publ) 22 BONEX.ST	4.90%	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
23	OrganoClick AB (publ) 23 ORGC.ST	4.08%	Dec. 31, 2023	USD 0.25	0.32%	Sweden
24	Precise Biometrics AB (publ) 24 PREC.ST	-1.31%	Dec. 31, 2023	USD 0.43	-0.78%	Sweden
25	Sprint Bioscience AB (publ) 25 SPRINT.ST	-4.12%	Dec. 31, 2023	USD 0.14	1.34%	Sweden
26	Corline Biomedical AB 26 CLBIO.ST	-6.74%	Dec. 31, 2023	USD 0.84	-0.17%	Sweden
27	Promimic AB (publ) 27 PRO.ST	-9.94%	Dec. 31, 2023	USD 1.88	0.68%	Sweden
28	Ellen AB (publ) 28 ELN.ST	-11.53%	Dec. 31, 2023	USD 0.09	1.68%	Sweden
29	Devyser Diagnostics AB (publ) 29 DVYSR.ST	-25.87%	Dec. 31, 2023	USD 10.16	-0.20%	Sweden
30	SenzaGen AB 30 SENZA.ST	-27.14%	Dec. 31, 2023	USD 0.61	0.68%	Sweden
31	Newbury Pharmaceuticals AB (publ) 31 NEWBRY.ST	-33.51%	Aug. 31, 2024	USD 0.30	-1.39%	Sweden
32	Bactiguard Holding AB (publ) 32 BACTI-B.ST	-44.11%	Dec. 31, 2023	USD 3.19	2.10%	Sweden
33	LifeClean International AB (publ) 33 LCLEAN.ST	-61.70%	Dec. 31, 2023	USD 0.18	4.90%	Sweden
34	Enzymatica AB (publ) 34 ENZY.ST	-80.78%	Dec. 31, 2023	USD 0.15	-2.28%	Sweden
35	Vitrolife AB (publ) 35 VITR.ST	-90.69%	Dec. 31, 2023	USD 18.25	2.79%	Sweden
36	Qlucore Ab (Publ) 36 QCORE.ST	-104.28%	April 30, 2024	USD 0.47	-0.26%	Sweden
37	OssDsign AB (publ) 37 OSSD.ST	-108.79%	Dec. 31, 2023	USD 1.01	1.76%	Sweden
38	Elicera Therapeutics AB (publ) 38 ELIC.ST	-152.13%	Dec. 31, 2023	USD 0.23	11.53%	Sweden
39	AcouSort AB (publ) 39 ACOU.ST	-158.31%	Dec. 31, 2023	USD 0.94	2.12%	Sweden
40	Nanexa AB (publ) 40 NANEXA.ST	-241.39%	Dec. 31, 2023	USD 0.20	2.06%	Sweden
41	Mendus AB (publ) 41 IMMU.ST	-343.48%	Dec. 31, 2023	USD 0.71	-2.02%	Sweden
42	Aptahem AB (publ) 42 APTA.ST	-380.49%	Dec. 31, 2023	USD 0.11	1.51%	Sweden
43	NextCell Pharma AB 43 NXTCL.ST	-384.31%	Aug. 31, 2024	USD 0.22	-6.29%	Sweden
44	BioInvent International AB (publ) 44 BINV.ST	-437.59%	Dec. 31, 2023	USD 2.74	1.67%	Sweden
45	Hansa Biopharma AB (publ) 45 HNSA.ST	-532.88%	Dec. 31, 2023	USD 2.91	-2.20%	Sweden
46	OptiCept Technologies AB (publ) 46 OPTI.ST	-547.18%	Dec. 31, 2023	USD 0.39	-0.45%	Sweden
47	Egetis Therapeutics AB (publ) 47 EGTX.ST	-553.99%	Dec. 31, 2023	USD 0.52	0.51%	Sweden
48	CombiGene AB (publ) 48 COMBI.ST	-637.36%	Dec. 31, 2023	USD 0.21	0.68%	Sweden
49	Oncopeptides AB (publ) 49 ONCO.ST	-657.64%	Dec. 31, 2023	USD 0.12	-10.06%	Sweden
50	Scandinavian ChemoTech AB (publ) 50 CMOTEC-B.ST	-693.80%	Dec. 31, 2023	USD 0.13	-10.15%	Sweden

1 2

Frequently Asked Questions

Which Biotechnology company in Sweden has the highest EBITDA Margin ?

The Biotechnology company in Sweden with the highest EBITDA Margin is OncoZenge AB (publ) (Stockholm Stock Exchange: ONCOZ.ST) at 242,200.00%.
Which Biotechnology company in Sweden has the lowest EBITDA Margin ?

The Biotechnology company in Sweden with the lowest EBITDA Margin is Diamyd Medical AB (publ) (Stockholm Stock Exchange: DMYD-B.ST) at -108,995.38%.

What are the top 10 Biotechnology companies in Sweden by EBITDA Margin ?

The top 10 Biotechnology companies in Sweden by EBITDA Margin are OncoZenge AB (publ), Infant Bacterial Therapeutics AB (publ), BioArctic AB (publ), Genovis AB (publ.), RaySearch Laboratories AB (publ), BioGaia AB (publ), Swedish Orphan Biovitrum AB (publ), CellaVision AB (publ), I-Tech AB and Biotage AB (publ).
What are the bottom 10 Biotechnology companies in Sweden by EBITDA Margin ?

The bottom 10 Biotechnology companies in Sweden by EBITDA Margin are Diamyd Medical AB (publ), Lipum AB (publ), Qlife Holding AB (publ), SpectraCure AB (publ), Kancera AB (publ), Isofol Medical AB (publ), Nanologica AB (publ), IRLAB Therapeutics AB (publ), Prostatype Genomics AB (publ) and Biovica International AB (publ).